Ignite Creation Date:
2024-05-06 @ 3:18 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04586439
Status:
COMPLETED
Last Update Posted:
2021-03-08
First Post:
2020-10-12
Brief Title:
A Study of JNJ-73763989 in Healthy Chinese Adult Participants
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Study Overview
Official Title:
A Randomized Open-Label Parallel Single Dose Study to Investigate Pharmacokinetics Safety and Tolerability of JNJ-73763989 in Healthy Chinese Adult Participants
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the single-dose Pharmacokinetics of JNJ-73763976 and JNJ-73763924 following a subcutaneous SC injection of JNJ-73763989 JNJ-3989 in healthy Chinese adult participants at 2 different doses Dose 1 Panel A or Dose 2 Panel B
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 73763989HPB1004 | OTHER | Janssen Research Development LLC | None |